Additionally, IL‐33 prevents C. difficile‐associated mortality and epithelial disruption by promoting the activation of colonic ILC2, which in turn reduces pro‐inflammatory cytokines and increases anti‐inflammatory cytokines during CDI [29]. This evidence concerns the gene IL33 and clostridium difficile infection.